Navigation

Hepatitis C (genotype 1) - telaprevir [ID459]

Telaprevir for the treatment of genotype 1 chronic hepatitis C

Status: History
Expected date of issue: April 2012
Referral date: May 2011
Process: STA
Notes:

Scoped within Batch 17

Topic area:
  • Digestive system
  • Infectious diseases
 

NICE project team

Executive Lead: Gillian Leng
Technical Lead: Raisa Sidhu
Communications manager: Phil Ranson
Project manager: Jeremy Powell
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 21 October 2011
1st appraisal committee meeting: 01 February 2012
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • Janssen (telaprevir)

Patient/carer groups

  • British Liver Trust
  • Haemophilia Society
  • Hepatitis C Trust

Professional groups

  • Association of Clinical Biochemists - Microbiology Section
  • British Association for the Study of the Liver Nurses Forum
  • British HIV Association
  • British Infection Society (British Infection Association)
  • British Liver Nurses Forum
  • British Society of Gastroenterology
  • British Transplantation Society
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians
  • United Kingdom Clinical Pharmacy Association

Others

  • Department of Health
  • NHS Norfolk
  • Welsh Government

General

  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • Healthcare Improvement Scotland

Possible comparator manufacturer(s)

  • Roche Products (peginterferon alfa, ribavirin)
  • Merck Sharp and Dohme (peginterferon alfa, ribavirin)

Relevant research groups

  • MRC Clinical Trials Unit

Evidence Review Group

  • Southampton Health Technology Assessment Centre
  • National Institute for Health Research Health Technology Assessment Programme

Associated guideline groups

  • National Clinical Guidelines Centre

Associated public health groups

  • tbc

Top


 

Key documents

This page was last updated: 05 July 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.